| Id |
Subject |
Object |
Predicate |
Lexical cue |
| T1 |
0-45 |
Sentence |
denotes |
The IL-23/IL-17 axis as a therapeutic target. |
| T2 |
46-154 |
Sentence |
denotes |
T helper (Th) cells are known to differentiate into several distinct subsets depending on their environment. |
| T3 |
155-349 |
Sentence |
denotes |
The Interleukin 17 (IL-17)-producing subset Th17, which was reported and named in 2005, has been extensively analyzed because a strong association with inflammatory disorders has been suggested. |
| T4 |
350-540 |
Sentence |
denotes |
The condition in which Th17 cells are differentiated, critical transcription factors, and similarity and difference between mouse and human Th17 cells have been reported one after the other. |
| T5 |
541-672 |
Sentence |
denotes |
IL-23, which is believed to be important for the activation of Th17 cells, and IL-17 became promising targets for drug development. |
| T6 |
673-860 |
Sentence |
denotes |
In fact, biological drugs that block the IL-23/IL-17 axis have demonstrated to be highly effective against the inflammatory skin disease psoriasis and have been approved for clinical use. |
| T7 |
861-1014 |
Sentence |
denotes |
Here an overview and brief history of the basic research on Th17 cells are provided, with the latter full of surprises and unexpected twists in the plot. |
| T8 |
1015-1082 |
Sentence |
denotes |
The current state of biological drug development is also described. |
| T1 |
0-45 |
Sentence |
denotes |
The IL-23/IL-17 axis as a therapeutic target. |
| T2 |
46-154 |
Sentence |
denotes |
T helper (Th) cells are known to differentiate into several distinct subsets depending on their environment. |
| T3 |
155-349 |
Sentence |
denotes |
The Interleukin 17 (IL-17)-producing subset Th17, which was reported and named in 2005, has been extensively analyzed because a strong association with inflammatory disorders has been suggested. |
| T4 |
350-540 |
Sentence |
denotes |
The condition in which Th17 cells are differentiated, critical transcription factors, and similarity and difference between mouse and human Th17 cells have been reported one after the other. |
| T5 |
541-672 |
Sentence |
denotes |
IL-23, which is believed to be important for the activation of Th17 cells, and IL-17 became promising targets for drug development. |
| T6 |
673-860 |
Sentence |
denotes |
In fact, biological drugs that block the IL-23/IL-17 axis have demonstrated to be highly effective against the inflammatory skin disease psoriasis and have been approved for clinical use. |
| T7 |
861-1014 |
Sentence |
denotes |
Here an overview and brief history of the basic research on Th17 cells are provided, with the latter full of surprises and unexpected twists in the plot. |
| T8 |
1015-1082 |
Sentence |
denotes |
The current state of biological drug development is also described. |